US Research Integrity Head Temporarily Leaves Post

Kathy Partin, whose staff had expressed concerns about changes she instituted, was reportedly asked to leave.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Kathy Partin, ORIUS HEALTH AND HUMAN SERVICESFor two tumultuous years, Kathy Partin has led the US Office of Research Integrity (ORI), the government organization tasked with investigating claims of scientific misconduct among federal grant recipients. Retraction Watch reports that as of December 4, Partin will be on leave for three months, having been assigned a temporary position at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. The move marks what could be the end of Partin’s tenure as ORI director.

“They’ve basically told her she’s not going back,” Linda Schutjer, Partin’s former colleague at Colorado State University, tells Retraction Watch. “They’ve told her to take all her stuff out of her office, all of her personal things.” Retraction Watch was unable to confirm Schutjer’s claim with Partin, who declined to comment.

Partin’s leadership of the ORI has been controversial. As Science reported last year, Partin came in seeking to shake up the agency—conducting an office-wide review and bringing in a deputy from the National Science Foundation, whose integrity enforcement is more expansive.

ORI’s investigative staff responded at the time with complaints to supervisors at Health and Human Services (HHS), the department that oversees the ORI. In a letter to HHS, six staff members described “tensions ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies